ACS Patients Benefit From Bivalirudin During PCI, Long-Term Data Confirm

(MedPage Today) -- Bivalirudin (Angiomax) prevailed for periprocedural anticoagulation during percutaneous coronary intervention (PCI) in acute myocardial infarction (MI), according to a patient-level meta-analysis.
Among 15,254 patients with...